Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Biochemistry ; 59(4): 436-449, 2020 02 04.
Article in English | MEDLINE | ID: mdl-31814404

ABSTRACT

Huntington's disease is a genetic neurodegenerative disorder characterized by the formation of amyloid fibrils of the huntingtin protein (htt). The 17-residue N-terminal region of htt (Nt17) has been implicated in the formation of early phase oligomeric species, which may be neurotoxic. Because tertiary interactions with a downstream (C-terminal) polyproline (polyP) region of htt may disrupt the formation of oligomers, which are precursors to fibrillar species, the effect of co-incubation of a region of htt with a 10-residue polyP peptide on oligomerization and fibrillization has been examined by atomic force microscopy. From multiple, time-course experiments, morphological changes in oligomeric species are observed for the protein/peptide mixture and compared with the protein alone. Additionally, an overall decrease in fibril formation is observed for the heterogeneous mixture. To consider potential sites of interaction between the Nt17 region and polyP, mixtures containing Nt17 and polyP peptides have been examined by ion mobility spectrometry and gas-phase hydrogen-deuterium exchange coupled with mass spectrometry. These data combined with molecular dynamics simulations suggest that the C-terminal region of Nt17 may be a primary point of contact. One interpretation of the results is that polyP may possibly regulate Nt17 by inducing a random coil region in the C-terminal portion of Nt17, thus decreasing the propensity to form the reactive amphipathic α-helix. A separate interpretation is that the residues important for helix-helix interactions are blocked by polyP association.


Subject(s)
Huntingtin Protein/chemistry , Huntington Disease/metabolism , Amino Acid Sequence , Amyloid/chemistry , Amyloid/metabolism , Humans , Huntingtin Protein/genetics , Huntingtin Protein/metabolism , Huntington Disease/genetics , Kinetics , Microscopy, Atomic Force/methods , Molecular Dynamics Simulation , Nerve Tissue Proteins/metabolism , Nuclear Proteins/metabolism , Peptides/chemistry , Protein Conformation, alpha-Helical , Protein Structure, Secondary
2.
J Am Soc Mass Spectrom ; 30(6): 1102-1114, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30980382

ABSTRACT

Rapid, solution-phase hydrogen/deuterium exchange (HDX) coupled with mass spectrometry (MS) is demonstrated as a means for distinguishing small-molecule metabolites. HDX is achieved using capillary vibrating sharp-edge spray ionization (cVSSI) to allow sufficient time for reagent mixing and exchange in micrometer-sized droplets. Different compounds are observed to incorporate deuterium with varying efficiencies resulting in unique isotopic patterns as revealed in the MS spectra. Using linear regression techniques, parameters representing contribution to exchange by different hydrogen types can be computed. In this proof-of-concept study, the exchange parameters are shown to be useful in the retrodiction of the amount of deuterium incorporated within different compounds. On average, the exchange parameters retrodict the exchange level with ~ 2.2-fold greater accuracy than treating all exchangeable hydrogens equally. The parameters can be used to produce hypothetical isotopic distributions that agree (± 16% RMSD) with experimental measurements. These initial studies are discussed in light of their potential value for identifying challenging metabolite species.


Subject(s)
Deuterium Exchange Measurement/instrumentation , Metabolomics/instrumentation , Deuterium/chemistry , Deuterium Exchange Measurement/economics , Equipment Design , Hydrogen/chemistry , Mass Spectrometry/economics , Mass Spectrometry/instrumentation , Metabolomics/economics , Time Factors
3.
Curr Opin Chem Biol ; 42: 101-110, 2018 02.
Article in English | MEDLINE | ID: mdl-29241076

ABSTRACT

Ion mobility spectrometry-mass spectrometry (IMS-MS) provides information about the structures of gas-phase ions in the form of a collision cross section (CCS) with a neutral buffer gas. Indicating relative ion size, a CCS value alone is of limited utility. Although such information can be used to propose different conformer types, finer details of structure are not captured. The increased accessibility of IMS-MS measurements with commercial instrumentation in recent years has ballooned its usage in combination with separate measurements to provide enhanced data from which greater structural inferences can be drawn. This short review presents recent outstanding developments in scientific research that employs complementary measurements that when combined with IMS-MS data are used to characterize the structures of a wide range of compounds.


Subject(s)
Biochemical Phenomena , Ion Mobility Spectrometry/methods , Mass Spectrometry/methods , Molecular Structure , Ion Mobility Spectrometry/instrumentation , Mass Spectrometry/instrumentation
SELECTION OF CITATIONS
SEARCH DETAIL
...